Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 05, 2015 10:09 AM ET

Pharmaceuticals

Company Overview of AvMax, Inc.

Company Overview

AvMax, Inc. provides drug delivery technology to develop and commercialize pharmaceutical formulations which increase oral bioavailability and decrease inter and intra-patient variability in drug absorption. The company was founded in 1993 and is based in San Francisco, California.

385 Oyster Point Boulevard

Suite 9A

San Francisco, CA 94080

United States

Founded in 1993

Phone:

650-624-0130

Fax:

650-624-0131

Key Executives for AvMax, Inc.

President, Chief Executive Officer, and Director
Age: 73
Founder and Chairman
Age: 77
Director of Information Technology
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Prolong Pharmaceuticals, LLC United States
Tower Laboratories, Ltd. United States
Clarus Therapeutics, Inc. United States
JDP Therapeutics, Inc. United States
AccuMed, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AvMax, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.